Gilead Sciences, Inc. (GILD) EPS growth this year is 5.62%: Get Prepared for Trading Lift Off

Gilead Sciences, Inc. (NASDAQ: GILD) open the trading on Wednesday, with a bit cautious approach as it glided -1.66% to $70.89, before settling in for the price of $72.09 at the close. Taking a more long-term approach, GILD posted a 52-week range of $71.37-$87.86.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


It was noted that the giant of the Healthcare sector posted annual sales growth of 4.16% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 1.55%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.62%. This publicly-traded company’s shares outstanding now amounts to $1.25 billion, simultaneously with a float of $1.24 billion. The organization now has a market capitalization sitting at $88.31 billion. At the time of writing, stock’s 50-day Moving Average stood at $74.42, while the 200-day Moving Average is $77.13.

Gilead Sciences, Inc. (GILD) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Gilead Sciences, Inc.’s current insider ownership accounts for 0.10%, in contrast to 86.67% institutional ownership. According to the most recent insider trade that took place on Apr 02 ’24, this organization’s 10% Owner bought 485,250 shares at the rate of 0.76, making the entire transaction reach 368,790 in total value, affecting insider ownership by 7,345,473. Preceding that transaction, on Apr 01 ’24, Company’s Chief Medical Officer sold 2,000 for 72.96, making the whole transaction’s value amount to 145,920. This particular insider is now the holder of 96,304 in total.

Gilead Sciences, Inc. (GILD) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 12/30/2023 suggests? It has posted $1.72 earnings per share (EPS) not meeting the forecaster’s viewpoint (set at $1.76) by -$0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.71 per share during the current fiscal year.

Gilead Sciences, Inc.’s EPS increase for this current 12-month fiscal period is 5.62% and is forecasted to reach 7.45 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.12% through the next 5 years, which can be compared against the 1.55% growth it accomplished over the previous five years trading on the market.

Gilead Sciences, Inc. (NASDAQ: GILD) Trading Performance Indicators

Let’s observe the current performance indicators for Gilead Sciences, Inc. (GILD). It’s Quick Ratio in the last reported quarter now stands at 1.27. The Stock has managed to achieve an average true range (ATR) of 1.08. Alongside those numbers, its PE Ratio stands at $15.74, and its Beta score is 0.20. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.26. Similarly, its price to free cash flow for trailing twelve months is now 11.90.

In the same vein, GILD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 4.50, a figure that is expected to reach 1.58 in the next quarter, and analysts are predicting that it will be 7.45 at the market close of one year from today.

Technical Analysis of Gilead Sciences, Inc. (GILD)

[Gilead Sciences, Inc., GILD] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 16.26% While, its Average True Range was 1.02.

Raw Stochastic average of Gilead Sciences, Inc. (GILD) in the period of the previous 100 days is set at 1.11%, which indicates a major fall in contrast to 4.40% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 13.33% that was lower than 26.29% volatility it exhibited in the past 100-days period.